This Month
Prescription drug price freeze until 2026
Moves to limit price increases for prescription holders will come into force from January 1 next year.
- Tom McIlroy
Using Ozempic before surgery may be dangerous
Even if users follow “nil by mouth” instructions before an operation, they may still have food in their stomachs when they are wheeled into the operating theatre.
- Jill Margo
New deal! Five V Capital are creatures of Habit
Allied health providers have proved popular – and profitable – for a number of investors, including Quadrant Private Equity, Next Capital and Adamantem Capital.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Should doctors prescribe Ozempic for heart disease too?
A landmark study has shown Ozempic can reduce the risk of death in people with serious heart problems who are overweight or obese but do not have diabetes.
- Jill Margo
Ozempic helped after my heart attack, but it’s not the full solution
Tony Mellis knew something untoward was happening in his body, but so much more was happening in his life, he didn’t have time to see his doctor.
- Jill Margo
April
OpenAI’s model all but matches doctors in assessing eye problems
Ophthalmology has been a big focus of efforts to put AI to clinical use and fix obstacles to take-up, such as the tendency of models to ‘hallucinate’ by creating fictitious data.
- Michael Peel
Macquarie tips CSL shares to hit $500
Some of the biotechnology giant’s shareholders are sceptical about the investment bank’s call, which is detailed to clients in a 55-page note.
- Updated
- Alex Gluyas
- Exclusive
- Weight loss
Trish lost 25kg on replica Ozempic. She fears for patients like her
Patients like Trish Miller are afraid their weight loss will come to a halt as the regulator mulls a ban on replica anti-obesity drugs made by pharmacists.
- Nick Bonyhady
March
Multivitamins can help survival from bowel cancer
A study examining the dose-related influence of multivitamins on non-metastatic colorectal cancer is believed to be the first of its kind.
- Jill Margo
Common hormones used for contraception linked to brain tumours
Experts say a new French study should be a timely reminder to women to review their contraceptive needs periodically.
- Jill Margo
- Exclusive
- Russia-Ukraine war
Australian firm teaching advanced trauma surgery to Ukrainian doctors
Drones are shaking up the nature of battlefield injuries by limiting rapid rescues of wounded soldiers, leading to a surge in amputations.
- Ronald Mizen
Intermittent fasting may pose risks to your heart
A surprising new study has found that some intermittent fasters are more likely to die of heart disease.
- Updated
- Anahad O’Connor
I was stung by an Irukandji, this is what happened next
Most Aussies have heard about stinger season in north Queensland. But not everyone survives the full-body experience of encountering an Irukandji jellyfish.
- Will Willitts
Authorities raid pharmacy, plan off-brand Ozempic ban
The Therapeutic Goods Administration is cracking down on the supply of the wildly popular weight loss and diabetes medication.
- Nick Bonyhady
February
COVID-19 causes lasting cognitive, memory damage: major study
“Brain fog” was detectable in long and short-term cases, a detailed study suggests.
- Pam Belluck
Healthcare hopeful ADTY calls in potential backers for $50m check-up
A three-page flyer, seen by Street Talk, told interested parties the group has a pipeline of 25 healthcare practices ready for integration.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Gender
As kids, they thought they were trans. They no longer do
Detransitioners have few places to turn and often find themselves vilified by trans activists.
- Pamela Paul
- Exclusive
- Healthcare
Ozempic maker wants copycat products banned in Australia
The $600 billion drugmaker Novo Nordisk has become one of Europe’s largest companies off the success of its weight loss drug.
- Nick Bonyhady
January
Mesoblast surges on FDA ‘rare paediatric disease’ designation
Shares in Australian biopharmaceutical company Mesoblast jumped 25 per cent after Revascor was recognised as a potential treatment for heart disease in babies.
- Joanna Mather
How this ‘mercenary’ start-up scored $100m riding the Ozempic wave
Eucalyptus could have been a Millennial house of brands but instead it hitched its wagon to the breakout drug of 2023, triggering controversy and sales.
- Nick Bonyhady